Erlotinib News and Research

RSS
Erlotinib is a drug used to treat certain types of non-small cell lung cancer. It is also used together with gemcitabine to treat pancreatic cancer and is being studied in the treatment of other types of cancer. Erlotinib is a type of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Also called CP-358,774, erlotinib hydrochloride, OSI-774, and Tarceva.
New $5.3 million NIH grant will support researchers into understanding lung cancer recurrence

New $5.3 million NIH grant will support researchers into understanding lung cancer recurrence

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

New cellular pathway limits growth and spread of brain tumors

New cellular pathway limits growth and spread of brain tumors

New therapeutic strategy for lung cancer and associated secondary tumors

New therapeutic strategy for lung cancer and associated secondary tumors

Researchers discover new chemical weapon to fight against cancer

Researchers discover new chemical weapon to fight against cancer

UC San Diego researchers identify new therapeutic approach to kill cancer cells

UC San Diego researchers identify new therapeutic approach to kill cancer cells

Dacomitinib treatment for lung cancer increases overall survival but has more side effects

Dacomitinib treatment for lung cancer increases overall survival but has more side effects

New cell co-culture platform holds promise for future of personalized medicine

New cell co-culture platform holds promise for future of personalized medicine

Tobacco use causes precancerous cells to 'fertilize' nearby cells with cancerous changes

Tobacco use causes precancerous cells to 'fertilize' nearby cells with cancerous changes

Blood-based liquid biopsies can accurately track cancer treatment responses

Blood-based liquid biopsies can accurately track cancer treatment responses

Physicians more likely to prescribe drugs of manufacturers who paid them money

Physicians more likely to prescribe drugs of manufacturers who paid them money

Toxic effects of drugs in the lungs 'more widespread than thought'

Toxic effects of drugs in the lungs 'more widespread than thought'

Raman microscopy can help detect cancer drug resistance

Raman microscopy can help detect cancer drug resistance

Study: Erlotinib improves progression-free survival in EGFR mutated NSCLC

Study: Erlotinib improves progression-free survival in EGFR mutated NSCLC

Scientists uncover new way to make cancers sensitive to treatment

Scientists uncover new way to make cancers sensitive to treatment

Osimertinib provides progression-free survival benefit to Asian patients with EGFR-mutated NSCLC

Osimertinib provides progression-free survival benefit to Asian patients with EGFR-mutated NSCLC

Researchers use gold nanoshells to effectively release cancer drugs inside tumors

Researchers use gold nanoshells to effectively release cancer drugs inside tumors

New study finds enhanced impact of drug combination for FAP patients

New study finds enhanced impact of drug combination for FAP patients

UCLA scientists discover potential combination treatment for brain cancer in adults

UCLA scientists discover potential combination treatment for brain cancer in adults

Scientists discover how CD44s molecule gives brain cancer cells a survival advantage

Scientists discover how CD44s molecule gives brain cancer cells a survival advantage